Serum microRNA-33 levels in pre-diabetic and diabetic patients

Beydolah Shahouzehi1, Mostafa Eghbalian2, Hossein Fallah3

  • 1Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.

Insights

Serum miR-33 levels are elevated in pre-diabetic individuals, suggesting its potential role in monitoring pre-diabetes. Further research is needed to confirm its diagnostic viability.

Area of Science:

  • Biochemistry
  • Genetics
  • Endocrinology

Background:

  • Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia.
  • MicroRNAs (miRNAs) are small non-coding RNAs with regulatory roles in cellular functions and disease biomarkers.
  • Dysregulation of miRNAs is implicated in the pathogenesis of DM.

Purpose of the Study:

  • To investigate the expression levels of miR-33 in non-diabetic, pre-diabetic, and diabetic individuals.
  • To explore the correlation between serum miR-33 levels and metabolic parameters associated with diabetes.
  • To assess the potential of miR-33 as a biomarker for pre-diabetes.

Main Methods:

  • Serum samples were collected from three groups: non-diabetic controls, pre-diabetic individuals, and DM patients (n=15 per group).
  • Quantitative real-time PCR was employed to measure serum miR-33 expression levels.
  • Statistical analyses were performed to determine correlations between miR-33 and clinical/biochemical parameters.

Main Results:

  • Serum miR-33 expression was significantly higher in the pre-diabetic group compared to non-diabetic and diabetic groups (p < 0.001).
  • Diabetic subjects exhibited elevated fasting blood sugar (FBS), insulin levels, HOMA-IR, and triglycerides (TG).
  • miR-33 positively correlated with pre-diabetic state, sex, and FBS, and negatively with HOMA-IR.

Conclusions:

  • Elevated serum miR-33 levels are associated with the pre-diabetic state.
  • miR-33 may serve as a potential biomarker for monitoring the onset and progression of pre-diabetes.
  • Larger-scale studies are warranted to elucidate the precise mechanism and diagnostic utility of miR-33 in diabetes.

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K